recurrence and massive extraocular extension of choroidal malignant melanoma after vitrectomy and endoresection

Clicks: 409
ID: 180566
2014
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #31 of 456 articles by views in Bioinformatics

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 456 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Vitrectomy and endoresection is an alternative to enucleation for the treatment of large malignant choroidal melanoma. We report a rare case of extensive recurrence of choroidal malignant melanoma with extraocular extension 11 years after surgical endoresection without adjuvant treatment.
Reference Key
modarres2014indianrecurrence Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Mehdi Modarres;Asgari Rezanejad;Khalil Ghasemi Falavarjani
Journal Bioinformatics
Year 2014
DOI
10.4103/0301-4738.136247
URL
http://www.ijo.in/article.asp?issn=0301-4738;year=2014;volume=62;issue=6;spage=731;epage=733;aulast=Modarres
Keywords
Diabetic retinopathy Optical coherence tomography type 2 diabetes immunology agreement intraocular pressure power spectral-domain optical coherence tomography interleukin-1β axial length bilateral interleukin-10 enzyme-linked immunosorbent assay accommodation hypertensive retinopathy lens twin pregnancy color vision amplitude of accommodation vitrectomyophthalmology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.